Inhibition of TFF3 enhances sensitivity—and overcomes acquired resistance—to doxorubicin in estrogen receptor-positive mammary carcinoma

10.3390/cancers11101528

Saved in:
Bibliographic Details
Main Authors: Poh, H.M., Chiou, Y.S., Chong, Q.Y., Chen, R.-M., Rangappa, K.S., Ma, L., Zhu, T., Kumar, A.P., Pandey, V., Basappa, Lee, S.-C., Lobie, P.E.
Other Authors: MEDICINE
Format: Article
Published: MDPI AG 2021
Subjects:
Online Access:https://scholarbank.nus.edu.sg/handle/10635/209544
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
id sg-nus-scholar.10635-209544
record_format dspace
spelling sg-nus-scholar.10635-2095442024-11-14T13:18:52Z Inhibition of TFF3 enhances sensitivity—and overcomes acquired resistance—to doxorubicin in estrogen receptor-positive mammary carcinoma Poh, H.M. Chiou, Y.S. Chong, Q.Y. Chen, R.-M. Rangappa, K.S. Ma, L. Zhu, T. Kumar, A.P. Pandey, V. Basappa Lee, S.-C. Lobie, P.E. MEDICINE INST OF MOLECULAR & CELL BIOLOGY CANCER SCIENCE INSTITUTE OF SINGAPORE Acquired resistance Apoptosis Dose-dependent toxicity Doxorubicin Mammary carcinoma PI3K/AKT Trefoil factor 3 (TFF3) 10.3390/cancers11101528 Cancers 11 10 1528 2021-12-06T04:22:31Z 2021-12-06T04:22:31Z 2019 Article Poh, H.M., Chiou, Y.S., Chong, Q.Y., Chen, R.-M., Rangappa, K.S., Ma, L., Zhu, T., Kumar, A.P., Pandey, V., Basappa, Lee, S.-C., Lobie, P.E. (2019). Inhibition of TFF3 enhances sensitivity—and overcomes acquired resistance—to doxorubicin in estrogen receptor-positive mammary carcinoma. Cancers 11 (10) : 1528. ScholarBank@NUS Repository. https://doi.org/10.3390/cancers11101528 2072-6694 https://scholarbank.nus.edu.sg/handle/10635/209544 Attribution 4.0 International https://creativecommons.org/licenses/by/4.0/ MDPI AG Scopus OA2019
institution National University of Singapore
building NUS Library
continent Asia
country Singapore
Singapore
content_provider NUS Library
collection ScholarBank@NUS
topic Acquired resistance
Apoptosis
Dose-dependent toxicity
Doxorubicin
Mammary carcinoma
PI3K/AKT
Trefoil factor 3 (TFF3)
spellingShingle Acquired resistance
Apoptosis
Dose-dependent toxicity
Doxorubicin
Mammary carcinoma
PI3K/AKT
Trefoil factor 3 (TFF3)
Poh, H.M.
Chiou, Y.S.
Chong, Q.Y.
Chen, R.-M.
Rangappa, K.S.
Ma, L.
Zhu, T.
Kumar, A.P.
Pandey, V.
Basappa
Lee, S.-C.
Lobie, P.E.
Inhibition of TFF3 enhances sensitivity—and overcomes acquired resistance—to doxorubicin in estrogen receptor-positive mammary carcinoma
description 10.3390/cancers11101528
author2 MEDICINE
author_facet MEDICINE
Poh, H.M.
Chiou, Y.S.
Chong, Q.Y.
Chen, R.-M.
Rangappa, K.S.
Ma, L.
Zhu, T.
Kumar, A.P.
Pandey, V.
Basappa
Lee, S.-C.
Lobie, P.E.
format Article
author Poh, H.M.
Chiou, Y.S.
Chong, Q.Y.
Chen, R.-M.
Rangappa, K.S.
Ma, L.
Zhu, T.
Kumar, A.P.
Pandey, V.
Basappa
Lee, S.-C.
Lobie, P.E.
author_sort Poh, H.M.
title Inhibition of TFF3 enhances sensitivity—and overcomes acquired resistance—to doxorubicin in estrogen receptor-positive mammary carcinoma
title_short Inhibition of TFF3 enhances sensitivity—and overcomes acquired resistance—to doxorubicin in estrogen receptor-positive mammary carcinoma
title_full Inhibition of TFF3 enhances sensitivity—and overcomes acquired resistance—to doxorubicin in estrogen receptor-positive mammary carcinoma
title_fullStr Inhibition of TFF3 enhances sensitivity—and overcomes acquired resistance—to doxorubicin in estrogen receptor-positive mammary carcinoma
title_full_unstemmed Inhibition of TFF3 enhances sensitivity—and overcomes acquired resistance—to doxorubicin in estrogen receptor-positive mammary carcinoma
title_sort inhibition of tff3 enhances sensitivity—and overcomes acquired resistance—to doxorubicin in estrogen receptor-positive mammary carcinoma
publisher MDPI AG
publishDate 2021
url https://scholarbank.nus.edu.sg/handle/10635/209544
_version_ 1821226700513476608